These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 431057)

  • 1. Tumor-protective and -facilitating antigens from 3 M KCl-solubilized tumor extracts.
    Yamagishi H; Pellis NR; Kahan BD
    J Surg Res; 1979 Apr; 26(4):392-9. PubMed ID: 431057
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific and non-specific immunologic mechanisms of tumor growth facilitation.
    Yamagishi H; Pellis NR; Mokyr MB; Kahan BD
    Cancer; 1980 Jun; 45(12):2929-33. PubMed ID: 7388736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunology with particular reference to malignant melanoma.
    Maguire HC
    Int J Dermatol; 1975; 14(1):3-11. PubMed ID: 1092622
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of immunoprotective tumor antigens by preparative isotachophoresis.
    Saunders TL; Kahan BD; Pellis NR
    Cancer Immunol Immunother; 1983; 16(2):101-8. PubMed ID: 6559101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.
    Pellis NR; Kahan BD
    J Immunol; 1975 Dec; 115(6):1717-22. PubMed ID: 52676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiological properties of 1-butanol-extracted cell surface antigens.
    LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
    Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of cellular immunity to tumor cells.
    Cerilli J; Smith MC
    Surg Gynecol Obstet; 1972 May; 134(5):739-45. PubMed ID: 5064081
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens.
    Invernizzi G; Parmiani G
    Nature; 1975 Apr; 254(5502):713-4. PubMed ID: 1091865
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
    Tanaka T; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
    Simmons RL; Rios A
    Science; 1971 Nov; 174(4009):591-3. PubMed ID: 4940021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.
    Naito K; Oka T; Nomi S; Yamagishi H; Kahan BD
    Jpn J Cancer Res; 1989 Nov; 80(11):1119-26. PubMed ID: 2514172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
    Rios A; Simmons RL
    Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of sera from tumor bearing mice on immune reaction.
    Plavsić B; Jurin M; Ugarković B
    Acta Radiol Oncol; 1982; 21(2):129-32. PubMed ID: 6289613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor resistance in rats immunized to fetal tissues.
    Grant JP; Wells SA
    J Surg Res; 1974 May; 16(5):533-40. PubMed ID: 4831730
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase.
    Weiss L; Glaves D; Waite DA
    Int J Cancer; 1974 Jun; 13(6):850-62. PubMed ID: 4605279
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and characterization of a mesenchyme associated antigen from dimethylbenzanthracene induced rat fibrosarcoma.
    Chevrier A; Delpech B; Girard N; Nouel JP
    Biomedicine; 1979 Oct; 30(4):219-23. PubMed ID: 119557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.